Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$8.59 - $10.96 $3.78 Million - $4.82 Million
-439,853 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$9.8 - $12.89 $588,000 - $773,400
60,000 Added 15.8%
439,853 $4.76 Million
Q1 2019

May 10, 2019

BUY
$8.27 - $12.73 $265,897 - $409,294
32,152 Added 9.25%
379,853 $4.83 Million
Q3 2018

Nov 09, 2018

BUY
$14.31 - $17.65 $4.98 Million - $6.14 Million
347,701 New
347,701 $6.36 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $236M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.